Clinical Trial

A Study of MK-7240 in Healthy Participants (MK-7240-009)

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-11
Trial Details
NCT Number NCT07405177
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 330 participants
Start Date 2026-03-05
Primary Completion 2026-09-03 (estimated)
Study Completion 2026-09-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-10